Piperazine substituted indazole compounds as inhibitors of PARG
US12269820B2 · kind B2 · utility
0Cited by
8References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 22, 2023 |
| Grant date | Apr 8, 2025 |
| Priority date | — |
| Expiry date | Jun 8, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are compounds of Formula (I): or a pharmaceutically acceptable salt thereof. The provided compounds are useful Poly ADP-ribose glycohydrolase (PARG) inhibitors. Additional utilities and advantages are described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.